首款国产九价HPV疫苗今日开打
财联社·2025-12-04 10:55
Group 1 - The core viewpoint of the article highlights the launch of the domestically developed nine-valent HPV vaccine in Beijing, providing a more comprehensive and cost-effective option for cervical cancer prevention for women aged 9 to 45 [1] - This vaccine is the second nine-valent HPV vaccine globally and marks a significant step in breaking the long-standing monopoly of imported vaccines in the market [2]